rs121434277
Variant summary
Our verdict is Pathogenic. Variant got 22 ACMG points: 22P and 0B. PS1_Very_StrongPM1PM2PP3_ModeratePP5_Very_Strong
The NM_000016.6(ACADM):c.447G>A(p.Met149Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000105 in 1,613,532 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely pathogenicin ClinVar.
Frequency
Consequence
NM_000016.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 22 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACADM | NM_000016.6 | c.447G>A | p.Met149Ile | missense_variant | 6/12 | ENST00000370841.9 | NP_000007.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACADM | ENST00000370841.9 | c.447G>A | p.Met149Ile | missense_variant | 6/12 | 1 | NM_000016.6 | ENSP00000359878.5 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152150Hom.: 0 Cov.: 31
GnomAD4 exome AF: 0.0000109 AC: 16AN: 1461382Hom.: 0 Cov.: 30 AF XY: 0.0000124 AC XY: 9AN XY: 727000
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152150Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74312
ClinVar
Submissions by phenotype
Medium-chain acyl-coenzyme A dehydrogenase deficiency Pathogenic:4
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Apr 12, 2023 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 01, 1991 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 25, 2022 | For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ACADM protein function. ClinVar contains an entry for this variant (Variation ID: 3591). This missense change has been observed in individual(s) with MCAD deficiency (PMID: 1684086, 9158144). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces methionine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 149 of the ACADM protein (p.Met149Ile). - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Mar 21, 2024 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jun 13, 2014 | - - |
ACADM-related disorder Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 31, 2023 | The ACADM c.447G>A variant is predicted to result in the amino acid substitution p.Met149Ile. This variant has been reported, along with the common c.985A>G (p.Lys329Glu) variant, in patients with medium chain acyl-CoA dehydrogenase deficiency (MCADD), one of whom presented with clinical symptoms before newborn screening was completed (Yokota et al 1991. PubMed ID: 1684086; Andresen et al. 1997. PubMed ID: 9158144, described as M124I based on legacy nomenclature; Anderson et al. 2020. PubMed ID: 31836396). The c.447G>A and c.985A>G variants were reported to segregate with disease in siblings in two unrelated families. All four reported siblings were clinically asymptomatic (Andresen et al. 1997. PubMed ID: 9158144). In an expression study using E. coli cells, the p.Met149Ile substitution was reported to greatly reduce enzyme activity relative to control (Andresen et al. 1997. PubMed ID: 9158144). We have also observed this variant internally, in the compound heterozygous state with the c.985A>G variant, in more than one patient with positive newborn screen results for MCADD. Taken together, this variant is interpreted as likely pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at